{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:51:58Z","timestamp":1791150718797,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/bf02983818","type":"journal-article","created":{"date-parts":[[2008,11,6]],"date-time":"2008-11-06T11:33:39Z","timestamp":1225971219000},"page":"443-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Bisphosphonate Zoledronic Acid Induces Cytotoxicity in Human Myeloma Cell Lines with Enhancing Effects of Dexamethasone and Thalidomide"],"prefix":"10.1007","volume":"78","author":[{"given":"A. Ugur","family":"Ural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ilker","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferit","family":"Avcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Pekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Zerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oral","family":"Nevruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sengul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atilla","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,12,1]]},"reference":[{"key":"BF02983818_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","volume":"42","author":"H. Fleisch","year":"1991","unstructured":"Fleisch H. Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone disease.Drugs. 1991;42:919\u2013944.","journal-title":"Drugs."},{"key":"BF02983818_CR2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM199602223340802","volume":"334","author":"J Berenson","year":"1996","unstructured":"Berenson J, Lichtenstein A, Porter L, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma.N Engl J Med. 1996;334:488\u2013493.","journal-title":"N Engl J Med."},{"key":"BF02983818_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1365-2141.1998.00567.x","volume":"100","author":"E McCloskey","year":"1998","unstructured":"McCloskey E, MacLennan IC, Drayson MT, Chapman C, Dunn J, Kanis JA. A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma.Br J Haematol. 1998;100: 317\u2013325.","journal-title":"Br J Haematol."},{"key":"BF02983818_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jbmr.5650030210","volume":"3","author":"CWGM L\u00f6vik","year":"1988","unstructured":"L\u00f6vik CWGM, van der Pluijm G, van der Wee-Pals LJA, Bloys van Treslong-de Groat H, Bijvoet OLM. Migration and phenotypic transformation of osteoclast precursors in to mature osteoclasts: the effect of a bisphosphonate.J Bone Miner Res. 1988;3:185\u2013192.","journal-title":"J Bone Miner Res."},{"key":"BF02983818_CR5","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1172\/JCI114100","volume":"83","author":"DE Hughes","year":"1989","unstructured":"Hughes DE, Mac Donald BR, Russel RGG, Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.J Clin Invest. 1989;83:1930\u20131935.","journal-title":"J Clin Invest."},{"key":"BF02983818_CR6","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1172\/JCI115539","volume":"88","author":"M Sato","year":"1991","unstructured":"Sato M, Grassor G, Endo N, et al. Bisphosphonate action: alen- dronate localization in rat bone and effects on osteoclast ultra- structure.J Clin Invest. 1991;88:2095\u20132105.","journal-title":"J Clin Invest."},{"key":"BF02983818_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI114459","volume":"85","author":"A Carano","year":"1990","unstructured":"Carano A, Teitelbaym SA, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.J Clin Invest. 1990;85:456\u2013461.","journal-title":"J Clin Invest."},{"key":"BF02983818_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1046\/j.1365-2141.2002.03257.x","volume":"116","author":"S Yaccoby","year":"2002","unstructured":"Yaccoby S, Pearse RN, Johnson CL, Barlogie B, Choi Y, Epstein J. Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.Br J Haematol. 2002;116:278\u2013290.","journal-title":"Br J Haematol."},{"key":"BF02983818_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1046\/j.1365-2141.1997.2713086.x","volume":"98","author":"CM Shipman","year":"1997","unstructured":"Shipman CM, Rogers MJ, Apperley JF, Russel RGG, Croucher PI. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.Br J Haematol. 1997;98:665\u2013672.","journal-title":"Br J Haematol."},{"key":"BF02983818_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/sj.leu.2400892","volume":"12","author":"A Aparicia","year":"1998","unstructured":"Aparicia A, Gardner A, Tu Y, Savage A, Berenson J, Lichtenstein A. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.Leukemia. 1998;12:220\u2013229.","journal-title":"Leukemia."},{"key":"BF02983818_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/10428199809059253","volume":"32","author":"CM Shipman","year":"1998","unstructured":"Shipman CM, Rogers MJ, Apperley JF, Russel RGG, Craucher PI. Anti-tumour activity of bisphosphonates in human myeloma cells.Leuk Lymphoma. 1998;32:129\u2013138.","journal-title":"Leuk Lymphoma."},{"key":"BF02983818_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","volume":"16","author":"J Berenson","year":"1998","unstructured":"Berenson J, Lichtenstein A, Porter L, et al. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.J Clin Oncol. 1998;16: 593\u2013602.","journal-title":"J Clin Oncol."},{"key":"BF02983818_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1056\/NEJM199808063390609","volume":"339","author":"GR Mundy","year":"1998","unstructured":"Mundy GR,Yoneda T. Bisphosphonates as anticancer drugs.N Engl J Med. 1998;339:398\u2013400.","journal-title":"N Engl J Med."},{"key":"BF02983818_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1046\/j.1365-2141.1998.00976.x","volume":"103","author":"MV Dhodapkar","year":"1998","unstructured":"Dhodapkar MV, Singh J, Mehta J, et al. Anti-myeloma activity of pamidronate in vivo.Br J Haematol. 1998;103:530\u2013532.","journal-title":"Br J Haematol."},{"key":"BF02983818_CR15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","volume":"96","author":"V Kunzmann","year":"2000","unstructured":"Kunzmann V, Bauer E, Feurle J, WeiBinger F, Tony HP, Wilhelm M. Stimulation of T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.Blood. 2000;96: 384\u2013392.","journal-title":"Blood."},{"key":"BF02983818_CR16","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V96.9.2943","volume":"96","author":"T Hideshima","year":"2000","unstructured":"Hideshima T, Chauhan D, Shima Y, et al. Thalidomide and its analog overcome drug resistance of human multiple myeloma cells to conventional therapy.Blood. 2000;96:2943\u20132950.","journal-title":"Blood."},{"key":"BF02983818_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","volume":"91","author":"M Hallek","year":"1998","unstructured":"Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process.Blood. 1998;91:3\u201321.","journal-title":"Blood"},{"key":"BF02983818_CR18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","volume":"163","author":"LG Corral","year":"1999","unstructured":"Corral LG, Haslett PAJ, Muller GW. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogs that are potent inhibitors of TNF-\u03b1.J Immunol. 1999;163: 380\u2013386.","journal-title":"J Immunol."},{"key":"BF02983818_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0022-1759(90)90187-Z","volume":"131","author":"M Ferrari","year":"1990","unstructured":"Ferrari M, Fornasiero MC, Isetta AM. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro.J Immunol Methods. 1990;131:165\u2013172.","journal-title":"J Immunol Methods"},{"key":"BF02983818_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi CA. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.J Immunol Meth. 1991;139:271\u2013279.","journal-title":"J Immunol Meth."},{"key":"BF02983818_CR21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/jbmr.5650111015","volume":"11","author":"MJ Rogers","year":"1996","unstructured":"Rogers MJ, Chilton KM, Caxon FP, Smith MO, Suri S, Russel GG. Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism.J Bone Miner Res. 1996;11:1482\u20131491.","journal-title":"J Bone Miner Res."},{"key":"BF02983818_CR22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0026-895X(25)09541-0","volume":"50","author":"KS Selander","year":"1996","unstructured":"Selander KS, M\u00f6nkk\u00f6nen J, Karhukorpi EK, Hark\u00f6nen P, Hannuniemi R, Vaananem K. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.Mol Pharmacol. 1996; 50:1127\u20131138.","journal-title":"Mol Pharmacol."},{"key":"BF02983818_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/cyto.990130802","volume":"13","author":"Z Darzynkiewicz","year":"1992","unstructured":"Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells measured by flow cytometry.Cytometry. 1992;13:795\u2013808.","journal-title":"Cytometry."},{"key":"BF02983818_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jbmr.5650090710","volume":"9","author":"MJ Rogers","year":"1994","unstructured":"Rogers MJ, Watts DJ, Russel RG, et al. Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum.J Bone Miner Res. 1994;9:1029\u20131039.","journal-title":"J Bone Miner Res."},{"key":"BF02983818_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jbmr.5650020209","volume":"2","author":"MG Cecchini","year":"1987","unstructured":"Cecchini MG, Felix H, Fleisch H, Cooper PH. Effects of bisphosphonates on proliferation and viability of mouse bone marrow- derived macrophages.J Bone Miner Res. 1987;2:135\u2013142.","journal-title":"J Bone Miner Res."},{"key":"BF02983818_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/0006-291X(89)92405-4","volume":"159","author":"M Zaida","year":"1989","unstructured":"Zaida M, Datta HK, Patchell A, Moonga B, Muclntyre I. Calcium- activated intracellular calcium elevation: a novel mechanism of osteoclast regulation.Biochem Biophys Res Commun. 1989;159: 68\u201371.","journal-title":"Biochem Biophys Res Commun."},{"key":"BF02983818_CR27","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1002\/eji.1830231247","volume":"23","author":"ZQ Ning","year":"1993","unstructured":"Ning ZQ, Murphy JJ. Calcium ionophore-induced apoptosis of human B cells is preceded by the induced expression of early response genes.Eur J Immunol. 1993;23:3369\u20133372.","journal-title":"Eur J Immunol."},{"key":"BF02983818_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0008-8749(90)90106-2","volume":"125","author":"F Ojeda","year":"1990","unstructured":"Ojeda F, Guarda MI, Maldonado C, Folch H. Protein kinase C involvement in thymocyte apoptosis induced by hydrocortisone.Cell Immunol. 1990;125:535\u2013542.","journal-title":"Cell Immunol."},{"key":"BF02983818_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1006\/bbrc.1995.1251","volume":"207","author":"T Kameda","year":"1995","unstructured":"Kameda T, Ishikawa H, Tustsni T. Detection and characterization of apoptosis in osteoclasts in vitro.Biochem Biophys Res Commun. 1995;207:753\u2013760.","journal-title":"Biochem Biophys Res Commun."},{"key":"BF02983818_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1006\/bbrc.1993.1246","volume":"191","author":"M Sarih","year":"1993","unstructured":"Sarih M, Sauvannavong V, Adam A. Nitric oxide synthase induces macrophage death by apoptosis.Biochem Biophys Res Commun. 1993;191:503\u2013508.","journal-title":"Biochem Biophys Res Commun."},{"key":"BF02983818_CR31","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1073\/pnas.89.7.3030","volume":"89","author":"T Nyugen","year":"1992","unstructured":"Nyugen T, Brunson D, Crespi CI, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide.Proc NatlAcad Sci USA. 1992;89:3030\u20133034.","journal-title":"Proc NatlAcad Sci USA"},{"key":"BF02983818_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood.V98.1.210","volume":"98","author":"EF Davies","year":"2001","unstructured":"Davies EF, Raje N, Hideshima T, et al. Thalidomide and immunomodulatory derivatives augment natural killer cell cyto- toxicity in multiple myeloma.Blood. 2001;98:210\u2013216.","journal-title":"Blood."},{"key":"BF02983818_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0145-2126(91)90093-9","volume":"15","author":"SJ Hatfill","year":"1991","unstructured":"Hatfill SJ, Fester ED, DeBeer DP, Bohm L. Induction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites.Leuk Res. 1991;15:129\u2013136.","journal-title":"Leuk Res."},{"key":"BF02983818_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1248\/bpb.25.597","volume":"25","author":"MG Marks","year":"2002","unstructured":"Marks MG, Shi J, Fry MO, et al. Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioal- lantoic membrane (CAM) assay and on tumor and endothelial cell proliferation.Biol Pharm Bull. 2002;25:597\u2013604.","journal-title":"Biol Pharm Bull."},{"key":"BF02983818_CR35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V85.4.863.bloodjournal854863","volume":"85","author":"B Klein","year":"1995","unstructured":"Klein B, Zhang XG, Lu ZY, Bataille R. Interleukin-6 in human multiple myeloma.Blood. 1995;85:863\u2013872.","journal-title":"Blood"},{"key":"BF02983818_CR36","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V84.9.3063.3063","volume":"84","author":"J Hardin","year":"1994","unstructured":"Hardin J, Macleod S, Grigorieva I, et al. Interleukin-6 prevents dexamethasone-induced myeloma cell death.Blood. 1994;84: 3063\u20133070.","journal-title":"Blood"},{"key":"BF02983818_CR37","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJM197411142912001","volume":"291","author":"LG Raisz","year":"1974","unstructured":"Raisz LG, Cooper RA, Schechter GP, Salmon S. Evidence for the secretion of an osteoclast stimulating factor in myeloma.N Engl J Med. 1974;291:1041\u20131046.","journal-title":"N Engl J Med."},{"key":"BF02983818_CR38","first-page":"105","volume":"88","author":"AD Savage","year":"1996","unstructured":"Savage AD, Belson DJ, Vescio RA, Lichtenstein AK, Berenson JR. Pamidronate reduces IL-6 production by bone marrow stroma from multiple myeloma patients [abstract].Blood. 1996; 88:105a.","journal-title":"Blood"},{"key":"BF02983818_CR39","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/sj.leu.2401770","volume":"14","author":"P Tassone","year":"2000","unstructured":"Tassone P, Forciniti S, Galea E, et al. Growth inhibition and syner- gistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines.Leukemia. 2000;14:841\u2013844.","journal-title":"Leukemia."},{"key":"BF02983818_CR40","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF03401909","volume":"2","author":"LG Corral","year":"1996","unstructured":"Corral LG, Muller GW, Moreira AL, et al. Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.Mol Med. 1996;2:506\u2013515.","journal-title":"Mol Med."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02983818\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02983818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T14:45:50Z","timestamp":1738507550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02983818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["BF02983818"],"URL":"https:\/\/doi.org\/10.1007\/bf02983818","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}